Dr. Julie Parsonnet MD

• 
  www.cjr.org/behind_the_news/whats_healthy.php?page=2 - [Cached Version]
  Published on: 9/24/2007    Last Visited: 9/24/2007  

  I called Dr. Julie Parsonnet, an epidemiologist at Stanford University who I had met at a conference in California recently, and asked for her take on Taubes' article.She agreed that despite a "veneer of negativity," his work mostly treats the distinction between epidemiological and clinical trial research fairly.Parsonnet emphasizes, though, that the latter can often be as problematic and unreliable as the former."All research has to be looked at in the context of everything else that's known about the subject," she told me. Taubes, to his credit, predicts in his piece that epidemiologists like Parsonnet "will argue that they are never relying on any single study," and that "this in turn leads to the argument that the fault is with the press, not the epidemiology."
  ...
  "The fundamental problem is not necessarily reconcilable here," Parsonnet told me, "because people have an innate desire to protect their health and the press has an innate desire to provide interesting information to sell newspapers."

• 
  www.microarray.org/sfgf/initRegistration.do - [Cached Version]
  Published on: 10/7/2008    Last Visited: 2/25/2008  

  Julie Parsonnet Stanford

• 
  oralcancernews.org/wp/category/ocf_in_the_news/ - [Cached Version]
  Published on: 11/7/2005    Last Visited: 9/14/2008  

  I don't say, 'I think I'll have a little less Epstein-Barr virus today,' " said Dr. Julie Parsonnet, a researcher at Stanford Comprehensive Cancer Center in California who focuses on infectious diseases."We are probably focusing on the wrong thing."
  
  Ultimately, Parsonnet believes that infections from viruses and bacteria combined account for at least a quarter of cancers and more in developing countries where untreated infections are more common.
  
  However, Parsonnet hopes the advent of the vaccine against cervical cancer, Gardasil, in 2006, may have begun to raise awareness.The maker, Merck & Co., ran national television advertisements that depicted average women expressing their surprise that cancer could be brought on by a viral infection."That for the first time brought infections to the public mind as a cause of cancer," Parsonnet said.
  ...
  Scientists don't know why different viruses are so selective in causing cancer, but Parsonnet believes the answer lies in the complex relationship between humans and the viruses inside them.The difference between a harmless virus and a deadly infection, she said, may come down to very specific details, or a cascade of unconnected events."Maybe herpes causes cancer but only if you previously had CMV (cytomegalovirus) and an exposure to hepatitis A before you were three," she speculated.

• 
  www.southkorea.embassy.gov.au/seol/relat1%5femap.html - [Cached Version]
  Published on: 10/7/2008    Last Visited: 12/4/2007  

  As Julie Parsonnet, Stanford's chief of infectious diseases, says: "Barry Marshall in many ways paved the way for people to believe you can't be as fixed to ideas you once thought were true."

• 
  www.cf-web.org/info-zone/cystic-l-news-98a - [Cached Version]
  Published on: 7/21/1999    Last Visited: 5/9/2002  

  "The efficacy of this is not as great as everybody would like to see, but I agree that people are waiting for this," said Julie Parsonnet of Stanford University School of Medicine.The committee unanimously rejected approval for community-acquired pneumonia, saying that the company's data was insufficient.Rhone-Poulenc presented data from four emergency use protocols and five comparative studies in a variety of gram-positive infections.The company continues to enroll patients in the emergency use protocol, which it says shows a clinical need for the drug.There have been requests for 180 patients in February alone, said the company.A total of 2,298 patients were studied in these phase III trials.In all, Synercid was given intravenously over one hour, every 6, 8 or 12 hours, for up to 14 days.

• 
  www.justscience.net/?cat=1 - [Cached Version]
  Published on: 2/11/2007    Last Visited: 3/18/2007  

  There's also the general unknown consequences of having a part of the human ecosystem go extinct: "We have no good sense of the microbial ecology of humans," says infectious-disease specialist Julie Parsonnet of Stanford University in California.

• 
  www.chrisbrimelow.com/aim/contacts.html - [Cached Version]
  Published on: 10/7/2008    Last Visited: 10/10/2007  

  Julie Parsonnet, Stanford, parsonnt@stanford.edu, 650.723.7920

• 
  www.utopiasilver.com/testimonials/cancer.htm - [Cached Version]
  Published on: 10/7/2008    Last Visited: 6/17/2008  

  Although the association between H. pylori and gastric cancer is among the better known examples of a bacterial cause for cancer, Julie Parsonnet, associate professor of medicine at the Stanford University School of Medicine's proposed ERID (Emerging and Re-emerging Infectious Diseases) program, points out that it is not the first such association to be made.She says that "people have long recognized that chronic skin and bone infections with bacteria can lead to aggressive skin cancers."

• 
  www.healthvirusnews.com/health/epstein-barr-virus/news/ - [Cached Version]
  Published on: 10/7/2008    Last Visited: 12/7/2007  

  I don't say, 'I think I'll have a little less Epstein-Barr virus today,' " said Dr. Julie Parsonnet, a researcher at Stanford Comprehensive Cancer Center in ...

• 
  forum.lef.org/default.aspx?f=42&m=25222 - [Cached Version]
  Published on: 1/5/2006    Last Visited: 5/16/2008  

  Dr. Julie Parsonnet, Professor of Medicine and of Health Research and Policy at Stanford University School of Medicine, wrote a Perspective of Marshall and Warren's achievement in the December 8, 2005 issue of the New England Journal of Medicine:

Page:  1 2 3 4 5